TECHWIRE 30
(CIX: WRAL30)  1,132.70  up arrow+0.08  (0.01 %)  Updated: 08:10 PM EST, Nov 21 2014
(NQ: Apple)  116.47  up arrow+0.16  (0.14 %)  Updated: 08:10 PM EST, Nov 21 2014
(NY: QUINTILES)  57.86  up arrow+0.11  (0.19 %)  Updated: 06:40 PM EST, Nov 21 2014
(OP: BASF SE)  91.10  up arrow+1.95  (2.19 %)  Updated: 05:20 PM EST, Nov 21 2014
(NQ: BioCryst)  10.33  down arrow-0.02  (-0.19 %)  Updated: 08:10 PM EST, Nov 21 2014
(NQ: BioDelivery)  14.29  down arrow-0.17  (-1.18 %)  Updated: 08:10 PM EST, Nov 21 2014
(NQ: CEMP)  13.63  up arrow+0.2  (1.49 %)  Updated: 08:10 PM EST, Nov 21 2014
(NQ: Cisco Systems)  26.88  up arrow+0.07  (0.26 %)  Updated: 08:10 PM EST, Nov 21 2014
(NQ: Cree)  35.51  up arrow+0.71  (2.04 %)  Updated: 08:10 PM EST, Nov 21 2014
(NQ: DARA)  0.81  up arrow+0.06  (7.93 %)  Updated: 08:10 PM EST, Nov 21 2014
(NY: EMC CORPORATION)  29.90  up arrow+0.04  (0.13 %)  Updated: 06:40 PM EST, Nov 21 2014
(NQ: Extreme Networks)  3.68  down arrow-0.14  (-3.66 %)  Updated: 08:10 PM EST, Nov 21 2014
(NQ: FB)  73.75  up arrow+0.15  (0.2 %)  Updated: 08:10 PM EST, Nov 21 2014
(NY: GLAXOSMITHKLINE)  46.40  up arrow+0.02  (0.04 %)  Updated: 06:40 PM EST, Nov 21 2014
(NQ: GOOG)  537.50  up arrow+2.67  (0.5 %)  Updated: 08:10 PM EST, Nov 21 2014
(NY: IBM)  160.92  up arrow+0.28  (0.17 %)  Updated: 06:40 PM EST, Nov 21 2014
(NY: LH)  100.46  down arrow-0.18  (-0.18 %)  Updated: 06:40 PM EST, Nov 21 2014
(OP: Lenovo Group)  27.55  up arrow+0.9  (3.38 %)  Updated: 05:20 PM EST, Nov 21 2014
(NY: MRK)  59.66  up arrow+0.28  (0.47 %)  Updated: 06:40 PM EST, Nov 21 2014
(NQ: Microsoft Corp)  47.98  down arrow-0.72  (-1.48 %)  Updated: 08:10 PM EST, Nov 21 2014
(NQ: NTAP)  42.31  up arrow+0.11  (0.26 %)  Updated: 08:10 PM EST, Nov 21 2014
(NY: NOVARTIS AG)  94.98  down arrow-0.29  (-0.3 %)  Updated: 06:40 PM EST, Nov 21 2014
(OP: Novozymes A/S)  45.82  down arrow-0.6  (-1.29 %)  Updated: 05:20 PM EST, Nov 21 2014
(NY: PFIZER)  30.45  up arrow+0.01  (0.03 %)  Updated: 06:40 PM EST, Nov 21 2014
(NQ: Pozen)  8.86  down arrow-0.07  (-0.78 %)  Updated: 08:10 PM EST, Nov 21 2014
(NY: RED HAT)  62.25  down arrow-0.54  (-0.86 %)  Updated: 06:40 PM EST, Nov 21 2014
(NQ: BBRY)  10.24  up arrow+0.19  (1.89 %)  Updated: 08:10 PM EST, Nov 21 2014
(NQ: Salix)  102.90  up arrow+2.47  (2.46 %)  Updated: 08:10 PM EST, Nov 21 2014
(NQ: SQI)  14.91  down arrow-0.01  (-0.07 %)  Updated: 08:10 PM EST, Nov 21 2014

Posts tagged “Video game industry”

August 31, 2006

Premium Lock Contract Dispute Breaks Out Between BioDelivery Sciences, One Of Its Investors

Morrisville-based BDSI says Clinical Development Capital sought to acquire rights to drug delivery technology now under trial. CDC seeks to terminate $7M investment.

August 4, 2006

Premium Lock BioDelivery Sciences Lands European Partner For Pain Drug Delivery System

Morrisville-based pharmaceutical company to receive $2.5 million upfront payment. BDSI also secures rights to delivery system in Europe, U.S. markets.

June 9, 2006

Premium Lock BioDelivery Sciences International To Review Strategy for Nausea Drug

FDA spells out possible ways for company to win marketing approval. BDSI to evaluate costs, time needed for additional testing.

May 17, 2006

Premium Lock BioDelivery Sciences Converts Stocks to $7 Million in Cash From Investor

Drug development firm is testing means of delivering powerful pain reliever through oral patch.

March 1, 2006

Premium Lock FDA Rejects Anti-Nausea Drug Licensed by BioDelivery Sciences

CEO says he is 'surprised and disappointed' by the FDA decision. BDSI is seeking a meeting to discuss findings.

January 9, 2006

Premium Lock BDSI Aims for $250 Million in Sales With New Painkiller

Morrisville-based drug development firm files investigational new drug application with FDA for treatment of moderate to severe pain.

August 12, 2004

Premium Lock Arius Pharmaceuticals Is Sold, But Operations Will Remain in RTP

Deal could be worth as much as $7 million for 2003 startup, which was launched by two former Glaxo executives. Arius is specialty pharmaceutical firm.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith

OUR INSIDERS

Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Scroll